SHOCKWAVE MED INC's ticker is SWAV and the CUSIP is 82489T104. A total of 222 filers reported holding SHOCKWAVE MED INC in Q4 2020. The put-call ratio across all filers is 0.31 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $984 | -34.9% | 4,942 | -6.7% | 0.00% | -33.3% |
| Q2 2023 | $1,512 | +67.1% | 5,295 | +26.8% | 0.00% | +50.0% |
| Q1 2023 | $905 | -60.9% | 4,177 | -62.9% | 0.00% | -66.7% |
| Q4 2022 | $2,312 | -99.9% | 11,245 | +3.4% | 0.01% | -25.0% |
| Q3 2022 | $3,022,000 | +357.9% | 10,870 | +214.4% | 0.01% | +300.0% |
| Q2 2022 | $660,000 | -3.8% | 3,457 | +4.4% | 0.00% | 0.0% |
| Q1 2022 | $686,000 | +18.1% | 3,311 | +1.5% | 0.00% | +100.0% |
| Q4 2021 | $581,000 | +5.4% | 3,262 | +21.7% | 0.00% | 0.0% |
| Q3 2021 | $551,000 | -16.5% | 2,681 | -23.0% | 0.00% | -50.0% |
| Q2 2021 | $660,000 | +97.0% | 3,481 | +35.1% | 0.00% | +100.0% |
| Q1 2021 | $335,000 | -9.5% | 2,576 | -28.0% | 0.00% | 0.0% |
| Q4 2020 | $370,000 | +37.5% | 3,576 | +0.6% | 0.00% | 0.0% |
| Q3 2020 | $269,000 | – | 3,554 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Prossimo Advisors, LLC | 18,758 | $3,735 | 8.81% |
| Matisse Capital | 22,175 | $4,415,043 | 3.12% |
| Atika Capital Management LLC | 116,500 | $23,195,150 | 3.04% |
| APEIRON CAPITAL Ltd | 18,300 | $3,643,530 | 2.44% |
| AtonRa Partners | 4,374 | $870,863 | 1.83% |
| Rhenman & Partners Asset Management AB | 81,000 | $16,127,100 | 1.74% |
| GILDER GAGNON HOWE & CO LLC | 549,173 | $109,340,363 | 1.66% |
| Eversept Partners, LP | 84,462 | $16,816,384 | 1.42% |
| Biondo Investment Advisors, LLC | 37,451 | $7,456,394 | 1.40% |
| DEEPWATER ASSET MANAGEMENT, LLC | 15,321 | $3,050,411 | 1.40% |